Laboratoire de Neurosciences Cognitives et Adaptatives, UMR 7364 CNRS, Université de Strasbourg, 67000 Strasbourg, France.
Neuropharmacology. 2013 Oct;73:31-40. doi: 10.1016/j.neuropharm.2013.05.005. Epub 2013 May 18.
Repeated cocaine exposure induces epigenetic factors such as DNA methyl-binding proteins, indicating that resulting changes in gene expression are mediated by alterations in brain DNA methylation. While the activity of protein phosphatase type-1 (PP1) is involved in cocaine effects and in brain plasticity, the expression of the PP1Cβ catalytic subunit gene was identified here as modulated by cocaine. Its expression was induced together with that of PP1Cγ in the brain of Methyl-CpG Binding Protein-2 (Mecp2) mutant mice, whereas PP1Cα expression was not affected, illustrating a different regulation of PP1C isoforms. Repeated cocaine administration was found to increase DNA methylation at the PP1Cβ gene together with its binding to Mecp2 in rat caudate putamen, establishing a link between two genes involved in cocaine-related effects and in learning and memory processes. Cocaine also increased DNMT3 expression, resulting in PP1Cβ repression that did not occur in the presence of DNMT inhibitor. Cocaine-induced PP1Cβ repression was observed in several brain structures, as evaluated by RT-qPCR, immunohistochemistry and Western blot, but did not occur after a single cocaine injection. Our data demonstrate that PP1Cβ is a direct MeCP2-target gene in vivo. They suggest that its repression may participate to behavioral adaptations triggered by the drug.
重复可卡因暴露会诱导表观遗传因子,如 DNA 甲基结合蛋白,表明基因表达的变化是由大脑 DNA 甲基化的改变介导的。虽然蛋白磷酸酶 1 型(PP1)的活性涉及可卡因效应和大脑可塑性,但这里鉴定出 PP1Cβ 催化亚基基因的表达受可卡因调节。其表达与 Methyl-CpG Binding Protein-2(Mecp2)突变小鼠大脑中的 PP1Cγ 一起被诱导,而 PP1Cα 的表达不受影响,说明了 PP1C 同工型的不同调节。研究发现,重复给予可卡因可增加大鼠尾壳核中 PP1Cβ 基因的 DNA 甲基化及其与 Mecp2 的结合,从而在参与可卡因相关效应和学习记忆过程的两个基因之间建立联系。可卡因还增加了 DNMT3 的表达,导致 PP1Cβ 被抑制,但在存在 DNMT 抑制剂的情况下不会发生。通过 RT-qPCR、免疫组织化学和 Western blot 评估,可卡因诱导的 PP1Cβ 抑制在几个脑结构中均有观察到,但单次可卡因注射后并未发生。我们的数据表明,PP1Cβ 是体内的直接 MeCP2 靶基因。它们表明,其抑制可能参与药物引发的行为适应。